1. DOP048 Vedolizumab levels during induction are associated with long-term clinical and endoscopic remission in patients with inflammatory bowel disease. (16th January 2018) Authors: Yarur, A; Bruss, A; Fox, C; Beniwal-Patel, P; Patel, A; Berens, B; Naik, S; Stein, D Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S064 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP60 Simplified rules to identify bio-naïve patients with Crohn's Disease with higher likelihood of clinical remission when initiating vedolizumab versus anti-TNFα therapies: Analysis of EVOLVE study data. (27th May 2021) Authors: Mantzaris, G; Yarur, A; Wang, S; Adsul, S; Kamble, P; Luo, M; Guerin, A; Billmyer, E; Nguyen, H; Bressler, B Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S095 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P159 Patients with Inflammatory Bowel Disease Present with Lower Trabecular Bone Scores. (27th May 2021) Authors: Yarur, A; Alexandra, B; Beniwal-Patel, P; Stein, D; Nunez, L; Berens, B; Shaina, S; Parakkal, D; Shaker, J; Jenna, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P325 Real-World Effectiveness And Safety Of Ustekinumab In Patients With Ulcerative Colitis: A Multi-Centre Study. (27th May 2021) Authors: Parakkal, D; Johnson, A; Fenster, M; Ramos, G; Zulqarnain, M; Ullman, T; Huang, L; Gutierrez, A; Bruss, A; Ungaro, R; Cohen, B; Gaurav, S; Anish, P; Sasankan, P; Costable, N; Pekow, J; Wang, W; Rubin, D; Ciorba, M; Beniwal-Patel, P Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P344 Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study. (25th January 2019) Authors: Ungaro, R; Fenster, M; Dimopoulos, C; Patel, A; Deepak, P; Syal, G; Yarur, A; Hirten, R; Christophi, G; Khatiwada, A; Lin, B; Colombel, J-F; Ha, C; Weisshof, R; Beniwal-Patel, P; Cohen, B; Pekow, J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P407 Efficacy and safety of etrasimod in subjects with moderately to severely active isolated proctitis: a subgroup analysis of the phase 3 ELEVATE UC 52 and ELEVATE UC 12 trials. (30th January 2023) Authors: Peyrin-Biroulet, L; Dubinsky, M C; Sands, B E; Panés, J; Schreiber, S; Reinisch, W; Feagan, B G; Danese, S; Yarur, A; D'Haens, G; Goetsch, M; Wosik, K; Wu, J; Modesto, I; McDonnell, A; Bartolome, L; Rabbat, C J; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P407 Real-world safety of tofacitinib in inflammatory bowel diseases: a multi-centre study. (25th January 2019) Authors: Yarur, A; Bixuan, L; Deepak, P; Khatiwada, A; Christophi, G; Ciorba, M; Ungaro, R; Fenster, M; Dimopoulos, C; Syal, G; Hirten, R; Colombel, J-F; Ha, C; Weisshof, R; Pekow, J; Patel, A; Beniwal-Patel, P; Cohen, B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P419 Clinical effectiveness and safety of first-line biologic vedolizumab as a monotherapy or combination therapy in ulcerative colitis and Crohn's disease patients: results from the EVOLVE study. (15th January 2020) Authors: Bressler, B; Yarur, A; Kopylov, U; Bassel, M; Brett, N; Colby, C; Lopez, C; Saha, S; Kifnidi, C; Agboton, C; Adsul, S; Demuth, D; Luo, M; Wang, S; Mantzaris, G J Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P476 Characterization of cardiac conduction abnormalities reported in the phase 3 ELEVATE programme. (30th January 2023) Authors: Vermeire, S; Yarur, A; Rubin, D T; Dubinsky, M C; Regueiro, M; Irving, P; Peyrin-Biroulet, L; Goetsch, M; Gu, G; Wu, J; Modesto, I; McDonnell, A; Rabbat, C J; Green, J; Anthopoulos, P Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P552 Higher Serum Ustekinumab Levels Correlate With Higher Rates Of Steroid-Free Deep Remission And Endoscopic Healing In Patients With Inflammatory Bowel Diseases. (21st January 2022) Authors: Yarur, A; Ungaro, R; Jain, A; Nunex, L; Spencer, E; Bruss, A; Berens, B; Beniwal-Patel, P; Dervieux, T; Dubinsky, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗